These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare provider...

Hospital-acquired (or nosocomial) pneumonia (HAP) is an important cause of morbidity and mortality despite improved prevention, antimicrobial therapy, and supportive care [1]. The treatment of non-ventilator-associated HAP (nvHAP) and ventilator-associated pneumonia (VAP) will be reviewed here.

Jul 19, 2017 · For patients with suspected VAP or HAP, an empiric antimicrobial regimen that has activity against Staphylococcus aureus and Pseudomonas aeruginosa should be used.

Classically, nosocomial pneumonia represents a spectrum of medical conditions that can be classified in two main groups: hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), with each having different pathogenesis, risk factors, diagnostic tools and treatment options.

Oct 1, 2020 · HAP is a new pneumonia (a lower respiratory tract infection verified by the presence of a new pulmonary infiltrate on imaging) that develops more than 48 hours after admission in nonintubated patients. VAP, the most common and fatal nosocomial infection of critical care, is a new pneumonia that develops after 48 hours of endotracheal intubation.

Jun 26, 2023 · Nosocomial pneumonia or hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs 48 hours or more after hospital admission and is not present at the admission time. Ventilator-associated pneumonia (VAP) represents a significant subset of HAP occurring in intensive care units (ICUs).

In Patients With Suspected HAP (Non-VAP), Should Treatment Be Guided by the Results of Microbiologic Studies Performed on Respiratory Samples, or Should Treatment Be Empiric?

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are important causes of morbidity and mortality, with mortality rates approaching 62%. HAP and VAP are the second most common cause of nosocomial infection overall, but are ...

Ventilator-associated pneumonia (VAP) and other healthcare-associated pneumonias are important, common healthcare-associated infections, but national surveillance for VAP has long been a challenge because of the lack of objective, reliable definitions.

Hospital-acquired pneumonia (HAP) is defined by an infection of the lung parenchyma that occurred at least 48 hours after hospital admission. Ventilator-associated pneumonia (VAP) develops in intensive care unit (ICU) patients mechanically ventilated for at least 48 hours 1, 2.